PDS Planning’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $935K | Sell |
13,543
-309
| -2% | -$21.3K | 0.07% | 137 |
|
|
2025
Q1 | $962K | Buy |
13,852
+546
| +4% | +$37.9K | 0.08% | 108 |
|
|
2024
Q4 | $1.14M | Buy |
13,306
+184
| +1% | +$15.8K | 0.1% | 89 |
|
|
2024
Q3 | $1.56M | Buy |
13,122
+723
| +6% | +$86.1K | 0.14% | 72 |
|
|
2024
Q2 | $1.77M | Buy |
12,399
+251
| +2% | +$35.8K | 0.18% | 65 |
|
|
2024
Q1 | $1.56M | Buy |
12,148
+408
| +3% | +$52.4K | 0.16% | 66 |
|
|
2023
Q4 | $1.21M | Buy |
11,740
+56
| +0.5% | +$5.79K | 0.14% | 69 |
|
|
2023
Q3 | $1.06M | Buy |
11,684
+688
| +6% | +$62.6K | 0.14% | 73 |
|
|
2023
Q2 | $890K | Buy |
10,996
+272
| +3% | +$22K | 0.11% | 83 |
|
|
2023
Q1 | $853K | Buy |
10,724
+3,280
| +44% | +$261K | 0.12% | 79 |
|
|
2022
Q4 | $504K | Buy |
7,444
+184
| +3% | +$12.5K | 0.08% | 94 |
|
|
2022
Q3 | $362K | Sell |
7,260
-246
| -3% | -$12.3K | 0.07% | 113 |
|
|
2022
Q2 | $418K | Buy |
7,506
+1,978
| +36% | +$110K | 0.08% | 110 |
|
|
2022
Q1 | $307K | Buy |
5,528
+846
| +18% | +$47K | 0.05% | 143 |
|
|
2021
Q4 | $262K | Sell |
4,682
-496
| -10% | -$27.8K | 0.05% | 154 |
|
|
2021
Q3 | $249K | Sell |
5,178
-250
| -5% | -$12K | 0.06% | 154 |
|
|
2021
Q2 | $227K | Buy |
+5,428
| New | +$227K | 0.06% | 163 |
|